Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Res ; 33(11): 1562-6, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19473701

ABSTRACT

To understand the mechanism behind aberrant Akt activation in T-ALL, PIK3CA, PTEN and SHIP1 expression and genotype were assessed. No cell lines or primary ALLs harbored PIK3CA mutations. PTEN was expressed in just one-third of the cell lines, but in two-thirds of the primary ALLs, though in the inactivated (phosphorylated) form. SHIP1 was undetectable in most primary ALL and in the T-ALL cell line Jurkat, which harbored a bi-allelic null mutation and a frame-shift deletion; primary ALL harbored the frame-shift as well as other translationally-inactivating deletions and insertions. The inactivation of SHIP1 could play a central role in the deregulation of Akt pathway and tumorigenesis, perhaps in conjunction with PTEN inactivation.


Subject(s)
Alternative Splicing , Gene Silencing , Mutation , Phosphoric Monoester Hydrolases/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Base Sequence , Child , DNA Primers , Humans , Inositol Polyphosphate 5-Phosphatases , Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...